SeekingAlpha · Jan 27, 2026
IBB: Beyond The 2025 Surge, Biotech Breakout
iShares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.

NYSE · IBBQ
Financial Services · Asset Management
$33.72
Down-$0.94 (-2.73%)
Updated Oct 18, 2026, 11:01 PM
SID Score
4.7/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · IBBQ
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 16, 2026
IBBQ closed at $33.72 after 20 trading sessions, down 3.25% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | $34.85 | $34.85 | $33.67 | $33.7154 | 17.88K |
| Oct 15, 2026 | $34.31 | $34.8796 | $34.23 | $34.66 | 29.69K |
| Oct 14, 2026 | $33.38 | $34.05 | $33.38 | $33.93 | 41.28K |
| Oct 13, 2026 | $34.02 | $34.02 | $33.4334 | $33.4334 | 46.7K |
| Oct 12, 2026 | $34.66 | $34.69 | $34.23 | $34.2482 | 21.19K |
| Oct 9, 2026 | $33.80 | $34.68 | $33.7079 | $34.62 | 31.48K |
| Oct 8, 2026 | $33.75 | $33.75 | $33.03 | $33.6249 | 28.32K |
| Oct 7, 2026 | $33.78 | $34.39 | $33.63 | $34.01 | 103.66K |
| Oct 6, 2026 | $34.94 | $34.94 | $33.659 | $33.90 | 33.14K |
| Oct 5, 2026 | $34.53 | $34.80 | $34.07 | $34.75 | 100.22K |
| Oct 2, 2026 | $34.78 | $34.78 | $34.20 | $34.37 | 134.91K |
| Oct 1, 2026 | $35.18 | $35.2874 | $34.42 | $34.42 | 67.42K |
| Sep 30, 2026 | $35.255 | $35.50 | $35.11 | $35.14 | 26.32K |
| Sep 29, 2026 | $35.36 | $35.47 | $34.83 | $35.24 | 124.33K |
| Sep 28, 2026 | $34.95 | $35.39 | $34.59 | $35.28 | 27.15K |
| Sep 25, 2026 | $35.20 | $35.20 | $34.755 | $35.00 | 34.44K |
| Sep 24, 2026 | $34.52 | $35.03 | $34.49 | $34.97 | 44.75K |
| Sep 23, 2026 | $35.50 | $35.53 | $34.56 | $34.76 | 39.88K |
| Sep 22, 2026 | $35.05 | $35.58 | $34.865 | $35.40 | 51.95K |
| Sep 21, 2026 | $34.59 | $34.9984 | $34.485 | $34.8495 | 37.96K |
The latest Smart Investors Daily articles mentioning IBBQ.
Company
Market Activity
Research & News
IBBQ research
Company profile and research snapshot.
The fund generally will invest at least 90% of its total assets in the securities that comprise the index. Strictly in accordance with its guidelines and mandated procedures, Nasdaq compiles the underlying index, which is a modified market capitalization weighted index that is designed to measure the performance of securities listed on the Nasdaq Stock Market that are classified as either biotechnology or pharmaceutical companies. The index may include securities of large-, mid- and small-capitalization companies. The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
SeekingAlpha · Jan 27, 2026
iShares Biotechnology ETF (IBB) is a BUY: large-cap biotech stability, M&A and AI catalysts, and 2026 upside. Read the full analysis here.
Zacks Investment Research · Jul 26, 2022
We highlight 4 ETFs that have started rebounding after a brutal sell-off
Zacks Investment Research · Jun 19, 2021
Dow has Worst Week of the Year on Rate Hike Fears
Zacks Investment Research · Jun 16, 2021
Biotech stocks are rallying this month; can the trend continue?
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning IBBQ.